Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure [NA]

View source ↗

Summary

This clinical trial update describes evaluating finerenone for cardiorenal protection in diabetic kidney disease and heart failure, with the study status listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kerendia (finerenone)

Snippet

Sponsor: College of Physicians and Surgeons Pakistan | Conditions: Diabetic Kidney Disease (DKD), Heart Failure | NA | Status: NOT_YET_RECRUITING